SYNAPSE MED Trademark

Trademark Overview


On Friday, October 8, 2021, a trademark application was filed for SYNAPSE MED with the United States Patent and Trademark Office. The USPTO has given the SYNAPSE MED trademark a serial number of 97065557. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 10, 2024. This trademark is owned by SYNAPSE MEDICINE. The SYNAPSE MED trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Downloadable computer software using artificial intelligence for medical prescription assistance, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence to avoid medical risks and contraindications and for drug interaction prevention, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for medical prescriptions analysis, namely, software for word processing and establishing standardized directories; none of the above products are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field

Telemedicine services; Prescription assistance modules in the nature of providing information in the field of medical prescriptions via telemedicine platforms; Providing advice relating to medical services provided via telecommunications technology; providing information in the field of telemedicine; providing information in the field of medical prescription; providing information in the field of medical prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field

Research in the field of artificial intelligence for computer software design for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Research in the field of artificial intelligence for computer software design for prescription analysis; Software design and development for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software design and development for prescription analysis; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories in the fields of medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories for prescription analysis; none of the above services are for us...
synapse med

General Information


Serial Number97065557
Word MarkSYNAPSE MED
Filing DateFriday, October 8, 2021
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 16, 2024

Trademark Statements


Description of MarkThe mark consists of the wording "SYNAPSE" in blue with the wording "MED" in blue superscripted to the right of the "E" in "SYNAPSE".
Goods and ServicesDownloadable computer software using artificial intelligence for medical prescription assistance, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence to avoid medical risks and contraindications and for drug interaction prevention, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for medical prescriptions analysis, namely, software for word processing and establishing standardized directories; none of the above products are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Goods and ServicesTelemedicine services; Prescription assistance modules in the nature of providing information in the field of medical prescriptions via telemedicine platforms; Providing advice relating to medical services provided via telecommunications technology; providing information in the field of telemedicine; providing information in the field of medical prescription; providing information in the field of medical prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field
NOT AVAILABLE"MED"
Goods and ServicesResearch in the field of artificial intelligence for computer software design for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Research in the field of artificial intelligence for computer software design for prescription analysis; Software design and development for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software design and development for prescription analysis; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories in the fields of medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories for prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field; Software as a service (SAAS) services featuring software modules for providing prescription assistance through telemedicine platforms

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSYNAPSE MEDICINE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address33000 Bordeaux
FR

Party NameSYNAPSE MEDICINE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address33000 Bordeaux
FR

Trademark Events


Event DateEvent Description
Tuesday, October 12, 2021NEW APPLICATION ENTERED
Monday, November 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 13, 2022ASSIGNED TO EXAMINER
Thursday, July 14, 2022NON-FINAL ACTION WRITTEN
Thursday, July 14, 2022NON-FINAL ACTION E-MAILED
Thursday, July 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 16, 2023SUSPENSION LETTER WRITTEN
Thursday, February 16, 2023LETTER OF SUSPENSION E-MAILED
Thursday, February 16, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 14, 2023SUSPENSION INQUIRY WRITTEN
Thursday, September 14, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, September 14, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, December 14, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 17, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, May 6, 2024ASSIGNED TO LIE
Monday, May 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2024EXAMINERS AMENDMENT E-MAILED
Friday, June 7, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, June 7, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 7, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, June 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT